| 706418 |
FRONTIERS IN ONCOLOGY |
Case Report: Re-Sensitization to Gefitinib in Lung Adenocarcinoma Harboring EGFR Mutation and High PD-L1 Expression After Immunotherapy Resistance, Which Finally Transform Into Small Cell Carcinoma |
2021-06-24 |
10.3389/fonc.2021.661034 |
Zhai Xiaoqian, Liu Jiewei, Liang Zuoyu, Li Zhixi, Liu Yanyang, Huang Lin, Wang Weiya, Luo Feng |
| 706417 |
FRONTIERS IN ONCOLOGY |
FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration |
2021-06-24 |
10.3389/fonc.2021.653005 |
Li Sisi, Huang Xiao-ting, Wang Meng-yao, Chen Dong-ping, Li Ming-yi, Zhu Yan-yi, Yu Yi, Zheng Lu, Qi Bin, Liu Jin-quan |
| 706416 |
FRONTIERS IN ONCOLOGY |
Prebiotic Mannan Oligosaccharide Pretreatment Improves Mice Survival Against Lethal Effects of Gamma Radiation by Protecting GI Tract and Hematopoietic Systems |
2021-06-24 |
10.3389/fonc.2021.677781 |
Sanguri Sweta, Gupta Damodar |
| 706415 |
FRONTIERS IN ONCOLOGY |
In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso |
2021-06-24 |
10.3389/fonc.2021.670809 |
Blatt Roni, Davidi Shiri, Munster Mijal, Shteingauz Anna, Cahal Shay, Zeidan Adel, Marciano Tal, Bomzon Zeev, Haber Adi, Giladi Moshe, Weinberg Uri, Kinzel Adrian, Palti Yoram |
| 706414 |
FRONTIERS IN ONCOLOGY |
Evaluation of the Lung Immune Prognostic Index in Non-Small Cell Lung Cancer Patients Treated With Systemic Therapy: A Retrospective Study and Meta-Analysis |
2021-06-24 |
10.3389/fonc.2021.670230 |
Huang Litang, Han Hedong, Zhou Li, Chen Xi, Xu Qiuli, Xie Jingyuan, Zhan Ping, Chen Si, Lv Tangfeng, Song Yong |
| 706413 |
FRONTIERS IN ONCOLOGY |
Myeloid Sarcoma Type of Acute Promyelocytic Leukemia With a Cryptic Insertion of RARA Into FIP1L1: The Clinical Utility of NGS and Bioinformatic Analyses |
2021-06-24 |
10.3389/fonc.2021.688203 |
Wang Yongren, Rui Yaoyao, Shen Ying, Li Jian, Liu Poning, Lu Qin, Fang Yongjun |
| 706412 |
FRONTIERS IN ONCOLOGY |
Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study |
2021-06-24 |
10.3389/fonc.2021.649766 |
Liu Li, Kalyani Farhin Shaheed, Yang Haiyan, Zhou Chunhua, Xiong Yi, Zhu Songlin, Yang Nong, Qu Jingjing |
| 706411 |
FRONTIERS IN ONCOLOGY |
Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy |
2021-06-24 |
10.3389/fonc.2021.695770 |
Grard Marion, Chatelain Camille, Delaunay Tiphaine, Pons-Tostivint Elvire, Bennouna Jaafar, Fonteneau Jean-François |
| 706410 |
FRONTIERS IN ONCOLOGY |
Nomogram for Predicting the Postoperative Venous Thromboembolism in Spinal Metastasis Tumor: A Multicenter Retrospective Study |
2021-06-24 |
10.3389/fonc.2021.629823 |
Zhang Hao-ran, Xu Ming-you, Yang Xiong-gang, Wang Feng, Zhang Hao, Yang Li, Qiao Rui-qi, Li Ji-kai, Zhao Yun-long, Zhang Jing-yu, Hu Yong-cheng |
| 706409 |
FRONTIERS IN ONCOLOGY |
Exploratory Analysis of 18F-3’-deoxy-3’-fluorothymidine (18F-FLT) PET/CT-Based Radiomics for the Early Evaluation of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer |
2021-06-24 |
10.3389/fonc.2021.601053 |
Fantini Lorenzo, Belli Maria Luisa, Azzali Irene, Loi Emiliano, Bettinelli Andrea, Feliciani Giacomo, Mezzenga Emilio, Fedeli Anna, Asioli Silvia, Paganelli Giovanni, Sarnelli Anna, Matteucci Federica |
